Sendai virus (SeV) is a murine parainfluenza virus widely used in biomedical research and as a model for respiratory infections. Due to its impact on laboratory rodent health and experimental outcomes, sensitive and specific detection of Sendai virus infections is critical. Serological diagnosis by enzyme-linked immunosorbent assay (ELISA) remains a gold standard for detecting anti-Sendai virus antibodies or viral antigen, offering fast and reliable diagnostic capabilities.
Diagnostic and Research Applications
- Serological screening of laboratory rodents to monitor SeV infection status.
- Detection of immune response by IgG and IgM antibody profiling.
- Quantitation of viral antigen in biological fluids or culture media.
- Research on Sendai virus pathogenesis, vaccine evaluation, and antiviral testing.
The assay provides rapid, reproducible results essential for ensuring biosecurity in vivariums and reliability of experimental data influenced by SeV infection. Its adaptability to different sample types makes it versatile for clinical and research laboratory usage.
Advantages and Specificity
Compared to traditional methods, ELISA kits using recombinant NP or peptide antigens exhibit improved specificity while maintaining high sensitivity. This reduces false positives caused by antibodies against other paramyxoviruses or contaminants in whole virion preparations. The sandwich ELISA format further enhances specificity through dual antibody recognition.
Kits designed for mouse or rat samples are tailored with reagents optimized for species-specific responses, enabling precise diagnostics. The limit of detection in some sandwich ELISAs approaches the nanogram per liter range, supporting early viral detection in asymptomatic infections.
Sendai virus ELISA kits represent robust tools for the detection of SeV infections based on recombinant nucleocapsid antigen or its immunodominant peptides. The kits play a vital role in preventing laboratory animal colony infections and supporting scientific studies involving Sendai virus. Continuous refinement of antigen selection and assay formats drives improvements in sensitivity, specificity, and ease of use, meeting the evolving needs of research and diagnostic laboratories.
